Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-26 @ 10:23 PM
Study NCT ID:
NCT00072566
Status:
COMPLETED
Last Update Posted:
2015-05-12
First Post:
2003-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-11
Completion Date Type:
ACTUAL
First Submit Date:
2003-11-04
First Submit QC Date:
None
Study First Post Date:
2003-11-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-14
Results First Submit QC Date:
None
Results First Post Date:
2015-05-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-08
Last Update Post Date:
2015-05-12
Last Update Post Date Type:
ESTIMATED